Capstone Investment Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,949
Closed -$504K 2364
2024
Q1
$504K Buy
6,949
+1,866
+37% +$125K ﹤0.01% 1553
2023
Q4
$311K Buy
+5,083
New +$302K ﹤0.01% 1575
2017
Q4
Sell
-8,186
Closed -$410K 611
2017
Q3
$410K Buy
8,186
+3,680
+82% +$188K 0.01% 343
2017
Q2
$237K Sell
4,506
-5,800
-56% -$311K 0.01% 528
2017
Q1
$572K Buy
+10,306
New +$568K 0.01% 562
2016
Q4
Sell
-16,006
Closed -$772K 1066
2016
Q3
$772K Buy
16,006
+7,200
+82% +$364K 0.02% 438
2016
Q2
$487K Buy
+8,806
New +$485K 0.01% 479

Other funds holding PBH

Capstone Investment Advisors's PBH Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 6,949 shares — an estimated $504K sold.

Capstone Investment Advisors first reported a position in PBH in Q2 2016 and held it in 7 quarters. The position peaked at $772K in Q3 2016. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 6,949 Prestige Consumer Healthcare shares in Q2 2024, an estimated $504K.
  • Capstone Investment Advisors first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 7 quarters.
  • Capstone Investment Advisors's Prestige Consumer Healthcare position peaked at $772K in Q3 2016.
  • 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.